Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100). Comparison with enalapril.
Hollenberg
Norman K
NK
Harvard Medical School, Brigham and Women's Hospital, Department of Radiology, Boston, MA 02115, USA.
D000284:Administration, Oral; D000577:Amides; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D018592:Cross-Over Studies; D004656:Enalapril / Q000008:administration & dosage / Q000494:pharmacology; D005650:Fumarates / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D000092502:Renin Inhibitors
D000577:Amides; D000804:Angiotensin II; D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D005650:Fumarates; D000092502:Renin Inhibitors; C446481:aliskiren